Announcements Trials
Browse Landscape

Phase

Phase 1 81Phase NA 40Phase 2 35Phase 1/2 30Phase EARLY_PHASE1 9Phase 3 6Phase 4 2Phase 2/3 2

Status

Unknown 1Completed 1

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Interventional 2

Sponsor

Cancer Type

Breast 277Gastrointestinal 10Gynecologic 9Genitourinary 9Thoracic 4Head & Neck 4Dermatologic 3Classical hematology 3CNS 3Sarcoma 2Plasma cell 2Other 2Lymphoid 2NET 1Endocrine 1

Conditions

Gastrointestinal Stromal Tumors 10Bone Neoplasms 9Sarcoma 8Neoplasms 3Multiple Myeloma 3Sarcoma, Kaposi 2Rhabdomyosarcoma 2Precursor Cell Lymphoblastic Leukemia-Lymphoma 2Pain 2Osteosarcoma 2Neoplasm Metastasis 2Lymphoma 2Carcinoma, Renal Cell 2Breast Neoplasms 2Anemia 2Acquired Immunodeficiency Syndrome 2Waldenstrom Macroglobulinemia 1Venous Thromboembolism 1Stomach Neoplasms 1Sarcoma, Ewing 1Rhabdomyosarcoma, Alveolar 1Renal Insufficiency 1Recurrence 1Rectal Neoplasms 1Psoriasis 1Prostatic Neoplasms 1Progressive Gastrointestinal Stromal Tumor 1Piebaldism 1Pancreatic Neoplasms 1Pain, Intractable 1

Interventions

pegylated granulocyte colony-stimulating factor 1Zoledronic Acid 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 4 × Breast Neoplasms × Sarcoma × Clear all
NCT00434447 2017-02-27

Long Term Efficacy and Safety of Zoledronic Acid Treatment in Patients With Bone Metastases

Novartis

Phase 4 Completed
73 enrolled
BreastGenitourinaryPlasma cellSarcoma

Bone Neoplasms, Breast Neoplasms, Multiple Myeloma, Prostatic Neoplasms, Renal Insufficiency

NCT02905916 2016-09-19

The Efficacy and Safety of PEG-rhG-CSF in Neutropenia After Chemotherapy

Peking University

Phase 4 Unknown
217 enrolled
BreastLymphoidSarcoma

Bone Neoplasms, Breast Neoplasms, Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡